Brief: India's Zim Laboratories June-Qtr Consol PAT Rises
Aug 4 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* JUNE-QUARTER CONSOL PAT 32.8 MILLION RUPEES VERSUS 865,000
RUPEES YEAR AGO
* JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 704.8 MILLION
RUPEES
VERSUS 674.1 MILLION RUPEES YEAR AGO
Source text: https://www.bseindia.com/xml-data/corpfiling/AttachLive/f21b1335-bd2c-420c-b084-367b2c820cef.pdf
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia